News for Healthier Living

Could GLP-1 Drugs Affect Risk of Epilepsy for People with Diabetes?

A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published on December 10, 2025, in Neurology(r), the medical journal of the American Academy of Neurology. Glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, have been used for diabetes and weight loss.

December 10, 2025


December 12 2025

December 11 2025

December 10 2025

December 9 2025

December 8 2025

December 7 2025

December 6 2025

December 5 2025

December 4 2025

December 3 2025

December 2 2025

December 1 2025

November 30 2025

November 29 2025

November 28 2025